MiR-181c-5p通过向PRKN来调节肺腺癌的进展
Jing Wang1, Man Li2, Meigui Wang3
1Department of Oncology, The Second People's Hospital of Liaocheng, Linqing, 252600, Shandong Province, China.
Biochemical genetics
|August 2, 2023
概括
微RNAmiR-181c-5p在肺腺癌中升高,并通过准帕金基因 (PRKN) 来驱动癌症的进展. 抑制miR-181c-5p抑制了瘤生长,表明其作为生物标记物的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 微RNAs (miRNAs) 在肺腺癌的发展中起着至关重要的作用.
- 在肺腺癌中,miR-181c-5p的特定作用和机制尚不清楚.
研究的目的:
- 研究miR-181c-5p在肺腺癌进展中的调节机制.
- 探索miR-181c-5p作为诊断和预测标记物的潜力.
主要方法:
- 定量实时PCR (RT-qPCR) 用于测量miR-181c-5p水平.
- 细胞活力,迁移和入侵试验 (CCK-8,Transwell).
- 生物信息预测 (miRDB) 和双露西法酶记者测试以确认目标基因 (PRKN).
主要成果:
- 在肺腺癌组织和细胞中,miR-181c-5p的表达显著上调.
- 下调miR-181c-5p抑制了细胞活力,迁移和入侵.
- 鉴定出PRKN是miR-181c-5p的直接标,表达的反相关性.
- PRKN调解了miR-181c-5p对肺腺癌进展的影响.
结论:
- miR-181c-5p通过向PRKN,促进肺腺癌的进展.
- miR-181c-5p代表了肺腺癌的潜在诊断和预测生物标志物.
- 向miR-181c-5p可能为肺腺癌提供新的治疗策略.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.3K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.0K
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
PI3K/mTOR/AKT Signaling Pathway
3.7K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.7K
Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K
